Cheung K S, Boisvert W, Lerner S A, Johnston M
J Med Chem. 1986 Oct;29(10):2060-8. doi: 10.1021/jm00160a045.
A large number of structurally diverse di- and tripeptides containing the alanine racemase inactivator beta-chloro-L-alanine (beta-Cl-LAla) have been synthesized, and their antibacterial properties in vitro have been evaluated. The dipeptides 1, 3-6, and 8-17 and the tripeptide 20 are all broad-spectrum antibacterial agents with considerable potency against both Gram-positive and Gram-negative species, but none of these peptides improves dramatically on the antibiotic efficacy of the previously described beta-Cl-LAla-beta-Cl-LAla, 9 (Cheung, K. S.; Wasserman, S. A.; Dudek, E.; Lerner, S. A.; Johnston, M. J. Med. Chem. 1983, 26, 1733). Gram-negative microorganisms, such as Escherichia coli, Hemophilus influenzae, Shigella flexneri, and Enterobacter species are consistently resistant to any haloalanyl peptide containing an alanyl residue, such as the dipeptide LAla-beta-Cl-LAla (2) and the tripeptides LMet-LAla-beta-Cl-LAla (7), LAla-LAla-beta-Cl-LAla (18), and LVal-LAla-beta-Cl-LAla (19). Correspondingly, these same organisms are protected from the bactericidal effects of 9 by supplementation of the growth medium with LAla or LAla-LAla. Escherichia coli JSR-O exposed to 9, but protected from lysis by sucrose stabilization, has only about 10% the normal level of intracellular alanine racemase activity. But when these cells are cultured in the presence of 9 with LAla supplementation, or in the presence of 2 with no supplementation, the alanine racemase levels are only about 20-30% below control values. These findings suggest that the resistance of Gram-negative species to chloroalanyl peptides containing alanyl units arises from the ability of LAla to protect the targeted racemase from inactivation by beta-Cl-LAla in vivo, an event which otherwise leads to cell death and lysis. Inactivation of alanine racemase in Gram-positive organisms appears not to be the cellular event that confers sensitivity of these species to a haloalanyl peptide.
已经合成了大量含有丙氨酸消旋酶失活剂β-氯-L-丙氨酸(β-Cl-LAla)的结构多样的二肽和三肽,并评估了它们的体外抗菌性能。二肽1、3 - 6、8 - 17和三肽20都是广谱抗菌剂,对革兰氏阳性菌和革兰氏阴性菌都有相当强的效力,但这些肽在抗菌效果上都没有比之前描述的β-Cl-LAla-β-Cl-LAla(9)有显著提高(Cheung,K. S.;Wasserman,S. A.;Dudek,E.;Lerner,S. A.;Johnston,M. J. Med. Chem. 1983,26,1733)。革兰氏阴性微生物,如大肠杆菌、流感嗜血杆菌、福氏志贺菌和肠杆菌属,始终对任何含有丙氨酰残基的卤代丙氨酰肽具有抗性,如二肽LAla-β-Cl-LAla(2)和三肽LMet-LAla-β-Cl-LAla(7)、LAla-LAla-β-Cl-LAla(18)和LVal-LAla-β-Cl-LAla(19)。相应地,通过在生长培养基中添加LAla或LAla-LAla,可以保护这些相同的生物体免受9的杀菌作用。暴露于9但通过蔗糖稳定化防止裂解的大肠杆菌JSR-O,其细胞内丙氨酸消旋酶活性仅为正常水平的约10%。但是当这些细胞在添加LAla的9存在下培养,或在不添加任何物质的2存在下培养时,丙氨酸消旋酶水平仅比对照值低约20 - 30%。这些发现表明,革兰氏阴性菌对含有丙氨酰单元的氯代丙氨酰肽的抗性源于LAla在体内保护目标消旋酶不被β-Cl-LAla失活的能力,否则这一事件会导致细胞死亡和裂解。革兰氏阳性生物体中丙氨酸消旋酶的失活似乎不是这些物种对卤代丙氨酰肽敏感的细胞事件。